What sector does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) operate in?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current stock price?
As of the latest data, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price is HK$2.81, with a previous close of HK$2.82. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd lost -HK$0.01 in the last trading session, representing a -0.35% loss.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current market capitalization?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd market cap is approximately 955.40 million.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Earnings Per Share (EPS)?
The trailing EPS is -HK$0.04.
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) pay dividends?
Yes. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 2.28% and an estimated annual payout of HK$0.06 per share.
When is the next ex-dividend date for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349)?
The next ex-dividend date is scheduled for January 10, 2026.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) beta (volatility) score?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd has a beta of 0.253, indicating lower volatility than the overall market.